DNA adduct level in lung tissue may act as a risk biomarker of lung cancer
- 1 July 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (11) , 1381-1388
- https://doi.org/10.1016/s0959-8049(00)00131-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patientsCarcinogenesis: Integrative Cancer Research, 1998
- Role of wild type p53 in the G2 phase: regulation of the γirradiation-induced delay and DNA repairOncogene, 1997
- DNA adducts as exposure biomarkers and indicators of cancer risk.Environmental Health Perspectives, 1997
- Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humansPharmacogenetics, 1995
- Genetic Polymorphism of Cytochromes P450 1A1, 2D6 and 2E1: Regulation and Toxicological SignificanceJournal of Occupational and Environmental Medicine, 1995
- Correlation between meteorological conditions and mutagenicity of airborne particupate samples in a tropical monsoon climate area from Kaohsiung City, TaiwanEnvironmental and Molecular Mutagenesis, 1994
- DNA adducts in bronchial biopsiesInternational Journal of Cancer, 1991
- DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlalbelling assayCarcinogenesis: Integrative Cancer Research, 1991
- Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cellsInternational Journal of Cancer, 1990
- Correlation of DNA adduct levels in human lung with cigarette smokingNature, 1988